Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00158262 · ClinicalTrials.gov registry record · Phase 4

Effect of Propranolol on Preventing Posttraumatic Stress Disorder

A Phase 4 study of Post Traumatic Stress Disorder, sponsored by Massachusetts General Hospital.

Completed
Registry status
Phase 4
Development phase
43
Enrollment target
2
Study locations

NCT00158262 is a Phase 4 study of Post Traumatic Stress Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 43 participants, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00158262, a Phase 4 study of Post Traumatic Stress Disorder, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
Phase 4
Development phase
43 participants
Enrollment target
2
Study locations

Study Summary

This study will assess the effectiveness of taking propranolol soon after a traumatizing incident in reducing the incidence and severity of posttraumatic stress disorder in acutely traumatized individuals.

Conditions Studied

Post Traumatic Stress Disorder

Interventions

  • DRUG Placebo
  • DRUG Propranolol

Study Locations (2)

Massachusetts

  • Massachusetts General Hospital - Boston
  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2004-09
Est. Completion 2008-05
Phase Phase 4

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00158262

The ClinicalTrials.gov registry entry for NCT00158262 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,117-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (96% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00158262 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00158262 about?

NCT00158262 is a clinical study titled "Effect of Propranolol on Preventing Posttraumatic Stress Disorder". This study will assess the effectiveness of taking propranolol soon after a traumatizing incident in reducing the incidence and severity of posttraumatic stress disorder in acutely traumatized individuals.

What is the current status of trial NCT00158262?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 43 participants. The study started on 2004-09. Estimated completion is 2008-05.

What conditions does trial NCT00158262 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder.

What interventions are being tested in trial NCT00158262?

The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG).

Who is sponsoring clinical trial NCT00158262?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00158262 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Post Traumatic Stress Disorder

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.